| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |